The short explanation
EGFR is a gene that helps control how cells grow. In some lung cancers, especially a type called adenocarcinoma, this gene has a change, called a mutation, that drives the cancer to grow. Finding it is important because there are targeted medicines designed to block this signal. EGFR mutations are more common in people who never smoked and in Asian patients, including many in India. For many people with this mutation, targeted therapy taken by mouth can control the cancer better than standard chemotherapy, often with different side effects.
What depends on your situation
The parts of this that change from person to person. Uncertainty is stated, not hidden.
- Targeted treatment is not a cure for advanced lung cancer, but it can shrink the tumour and help people live longer with a good quality of life. Over time, the cancer can become resistant, and doctors then look for other options.
- Some targeted medicines are expensive. Ask the oncologist whether they are covered under PM-JAY, state schemes or patient assistance programmes.
- The stage of the cancer and his general health will also guide treatment.
What this answer cannot determine
The boundary of online education. These need a clinician who can see you.
- This cannot decide your father's treatment. His oncologist will consider the full report, stage and health.
Questions for your clinician
Take these with you. You can add any of them to an appointment card.
- Which targeted treatment is suitable for him?
- What side effects should we watch for?
- What is the cost and is it covered?
- How will we know if treatment is working?
When to seek help
Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.
Emergency — call 112 now
- Call 112 or 108 if he becomes severely breathless or coughs up a large amount of blood.
Raise it at a routine appointment
- Discuss the treatment plan at his next oncology appointment.
Sources
The evidence this explanation is built on.
- Lung cancer National Cancer Institute (NIH)
- Lung cancer NHS
- Tobacco — fact sheet World Health Organization
Who wrote and reviewed this
Every AskHim answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.
- Author
- AskHim Editorial (AI-assisted)
- Clinical reviewer
- Nobody yet No clinician has signed this answer off. That is what the “Editorially reviewed” badge means, and why it does not say “Clinically reviewed”. It was written and checked by AskHim’s editorial team against the sources listed above, and it is queued for a clinician who works in this area.
- Review status
- Editorially reviewed
- Last reviewed
- Last reviewed 11 November 2026
- Version
- 1
Correction history
Substantive changes are listed, not quietly edited away.
No corrections have been made since this answer was first published.
Did this answer your question?
Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.
“Explain more simply” asks which part was hard to follow, so the author knows what to rewrite. “My question is different” tells the editorial team this answer missed your point, then lets you ask your own question privately. Nothing about you is sent with either.
Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.